Fraunhofer USA CMB Company Profile
Fraunhofer USA CMB, a division of Fraunhofer USA, Inc., is a not-for-profit research organization whose mission is to develop safe and effective vaccines targeting infectious diseases and autoimmune disorders. CMBâs technology provides a safe, rapid and economical alternative for vaccine production. The Center conducts research in the area of plant biotechnology, utilizing new, cutting edge technologies to assist with the diagnosis, prevention and treatment of human and animal diseases. The Center houses individuals with expertise and excellence in plant virology, pathology, molecular biology, immunology, vaccinology, protein engineering, and biochemistry. Further information is available at www.fraunhofer-cmb.org.
News Articles
(Fraunhofer-Gesellschaft) The internationalization of the Fraunhofer-Gesellschaft continues, with Europe's largest applied research organization further expanding its activities in South Korea. If bui...
Fraunhofer researchers earn environmental award: Concentrated sunlight
(Fraunhofer-Gesellschaft) An achievement for the solar experts: Dr. Andreas Bett of Fraunhofer ISE and Hansjörg Lerchenmüller of the Soitec Company received the 2012 DBU German Environmental Award....
Deep cleaning with carbon dioxide
(Fraunhofer-Gesellschaft) The Fraunhofer Cleaning Technology Alliance FAR is celebrating its 10th birthday at the parts2clean trade fair in Stuttgart, from Oct. 23 - 25 2012 in Hall 1, Booth F610/G707...
Fraunhofer supports continuation of 'Clean Sky' program
(Fraunhofer-Gesellschaft) Aviation will produce fewer emissions, save more fuel and become more environmentally friendly - these are the goals that leading aviation companies and research institutions...
Johns Hopkins University und Fraunhofer HHI
Johns-Hopkins-University und Fraunhofer Heinrich-Hertz-Institut unterzeichnen Grundsatzvereinbarung
Clean air: New paints break down nitrogen oxides
(Fraunhofer-Gesellschaft) Surfaces with photo-catalytic characteristics clean the air off nitrogen oxides and other health-endangering substances. Using a new test procedure, Fraunhofer researchers ca...
(Fraunhofer-Gesellschaft) Until now most adhesives have been manufactured from petroleum-based materials. However, they can also be obtained from renewable raw materials -- for example from proteins,...
Partnership for sustainable energy technologies
(Fraunhofer-Gesellschaft) Fraunhofer and the University of British Columbia UBC in Vancouver, Canada will partner to jointly develop technologies for sustainable energy production and supply.
Drugs and Medications
None
PubMed Articles
Binder free vertical aligned (VA) CNT/sulfur composite electrodes with high sulfur loadings up to 70 wt% were synthesized delivering discharge capacities higher than 800 mAh g(-1) of the total composi...
Study of the birth of a vortex at Fraunhofer zone.
We analytically and experimentally study the Fraunhofer diffraction of an optical vortex beam possessing noninteger values of the azimuthal index. We show that the Fraunhofer diffraction of this beam...
Formaldehyde in the ambient atmosphere: from an indoor pollutant to an outdoor pollutant?
Formaldehyde has been discussed as a typical indoor pollutant for decades. Legal requirements and ever-lower limits for formaldehyde in indoor air have led to a continual reduction in the amount of fo...
Integration in Bioanalysis: Technologies for Point-of-Care Testing.
: Biosensors, Lab-on-Chip technologies, and sensor-actor molecules are steps towards the integration of bioanalysis into small devices that will help in providing analysis where it is needed: the poin...
Microfluidics meets soft layer-by-layer films: selective cell growth in 3D polymer architectures.
We present here the micropatterns of layer-by-layer (LbL) assembled soft films generated using microfluidic platform that can be exploited for selective cell growth. Using this method, the issue of ce...
Clinical Trials
The aim of the study is to explore the contribution of pollen starch granules to the induced symptoms and airway inflammation in patients with allergic rhinitis and mild asthma in a contro...
Companies
Fraunhofer-Gesellschaft is the leading organization for applied research in Europe with 59 research institutes and 17,000 employees. Fraunhofer USA is a wholly-owned subsidiary headquartered in Plymo...
Fraunhofer USA Center for Molecular Biotechnology (CMB)
Fraunhofer Institute for Process Engineering and Packaging IVV
The Fraunhofer IVV is a competent and professional organization which carries out contract research and development work for industry. The activities are partly supported by publicly-funded explorator...
Fraunhofer USA CMB, a division of Fraunhofer USA, Inc., is a not-for-profit research organization whose mission is to develop safe and effective vaccines targeting infectious dise...
Fraunhofer USA Center for Molecular Biotechnology
Fraunhofer USA CMB, a division of Fraunhofer USA, Inc., is a not-for-profit research organization whose mission is to develop safe and effective vaccines targeting infectious dise...
More Information about "Fraunhofer USA CMB" on BioPortfolio
We have published hundreds of Fraunhofer USA CMB news stories on BioPortfolio along with dozens of Fraunhofer USA CMB Clinical Trials and PubMed Articles about Fraunhofer USA CMB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fraunhofer USA CMB Companies in our database. You can also find out about relevant Fraunhofer USA CMB Drugs and Medications on this site too.
